Metrics in Patient-Centered Drug Development Conference

Level setting work of collaborative groups has created actionable frameworks for meaningful engagement of patients in the medical product life cycle. Building on these concepts, groups such as TransCelerate and DIA-Tufts CSDD have been working to define medical product development operational activities and measures to encourage and support patient centricity. Additionally, some early adopters are anticipating what the regulatory environment for patient-centric medical product development will be as they structure their organizations and practices to become more patient-centric.